Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy.

Deivasigamani S, Kotamarti S, Mottaghi M, Adams ES, Ghoreifi A, Jhaveri H, Seguier D, Ivey MC, Zambon JP, Podichetty A, Can T, Groshopf J, Gupta RT, Moul JW, Polascik TJ

Open source

DOI
10.1002/pros.70175
Published
2026 Jun
Container
The Prostate
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pros.70175,
  title = {Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy.},
  author = {Deivasigamani S and Kotamarti S and Mottaghi M and Adams ES and Ghoreifi A and Jhaveri H and Seguier D and Ivey MC and Zambon JP and Podichetty A and Can T and Groshopf J and Gupta RT and Moul JW and Polascik TJ},
  year = {2026},
  journal = {The Prostate},
  doi = {10.1002/pros.70175},
  url = {https://doi.org/10.1002/pros.70175}
}

RIS

TY  - JOUR
TI  - Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy.
AU  - Deivasigamani S
AU  - Kotamarti S
AU  - Mottaghi M
AU  - Adams ES
AU  - Ghoreifi A
AU  - Jhaveri H
AU  - Seguier D
AU  - Ivey MC
AU  - Zambon JP
AU  - Podichetty A
AU  - Can T
AU  - Groshopf J
AU  - Gupta RT
AU  - Moul JW
AU  - Polascik TJ
PY  - 2026
JO  - The Prostate
DO  - 10.1002/pros.70175
UR  - https://doi.org/10.1002/pros.70175
ER  - 

APA

S, D., S, K., M, M., ES, A., A, G., H, J., D, S., MC, I., JP, Z., A, P., T, C., J, G., RT, G., JW, M., & TJ, P. (2026). Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy.. The Prostate. https://doi.org/10.1002/pros.70175

Source records